News August 31, 2021 BARDA seeks partners to develop agnostic diagnostic assays On August 23, 2021, BARDA's Division of Research, Innovation, and Ventures (DRIVe) opened a new area of interest (AOI) under… admin Love0
News August 30, 2021 2021 BioHealth Capital Region Mon, Sep 13, 2021 ONLY TWO WEEKS LEFT TO REGISTER Maryland, Virginia, and Washington, DC set the bar high for biotech innovation. Join us… admin Love0
News August 30, 2021 NCATS Small Business Funding: Resources and Tips to Commercialize Your Translational Science Innovation Join the National Center for Advancing Translational Sciences (NCATS) in collaboration with the Biotechnology Innovation Organization (BIO) on Wednesday, August… admin Love0
News August 30, 2021 NIA Fellow Daniela Lecca Joins BHI as New Postdoc Fellow Daniela Lecca completed her education in Italy, where she received her Ph.D. in Toxicology from the University of Cagliari for… admin Love0
BioTalk with Rich Bendis Podcast August 30, 2021 Maryland State Delegate, Lily Qi, Returns to BioTalk with Rich Bendis Lily Qi, Representative for the 15th legislative district in the Maryland House of Delegates. Joins BioTalk to discuss her career,… admin Love0
News August 30, 2021 Maryland State Delegate, Lily Qi, Returns to BioTalk with Rich Bendis Lily Qi, Representative for the 15th legislative district in the Maryland House of Delegates. Joins BioTalk to discuss her career,… admin Love0
News August 29, 2021 Maryland-based Emergent BioSolutions begins trials of its plasma-derived therapy for COVID Emergent BioSolutions Inc. is conducting phase clinical 3 trials of its plasma-derived therapy for outpatient treatment of COVID-19, the company… admin Love0
News August 29, 2021 Machine learning in cardiovascular trials Automating adjudication of events in cardiovascular trials Clinical trials for cardiovascular (CV) disease are time consuming and expensive to run,… admin Love0
News August 29, 2021 A public-private partnership is needed to develop new antivirals – STAT The U.S. government’s announcement that it is investing $3 billion into research on antiviral medicines for Covid-19 is a step… admin Love0
News August 29, 2021 Health Tech: Harsha Rajasimha On How JEEVA’s Technology Can Make An Important Impact In Our Overall Wellness | by Dave Philistin, CEO of Candor | Authority Magazine | Aug, 2021 | Medium Thank you so much for joining us in this interview series. Before we dive in, our readers would love to… admin Love0